Latest Health News
WHO Renews Commitment to Leprosy-Free World Ahead of World Leprosy Day
The World Health Organization renewed its commitment to eliminate leprosy, highlighting partnerships like with Novartis for free multidrug therapy access. In 2024, 172,717 new cases were reported globally, but 55 areas had zero cases. Efforts focus on early detection, contact screening, and reducing stigma.
US Withdrawal from WHO Threatens Global Disease Surveillance
The US is withdrawing from the World Health Organization effective this week, disrupting influenza surveillance and outbreak responses for diseases like mpox and Ebola. This shift allows China to become the largest WHO contributor, potentially steering priorities. Canada's measles resurgence underscores risks of weakened global health coordination.
Donor Nations Slash Funding for Global Fund, Risking Millions of Lives
Major donors pledged only $11.85 billion for the Global Fund's 2026-2028 cycle, far short of $18 billion needed for AIDS, TB, and malaria programs. The US cut from $6B to $4.6B, while others like Sweden reduced significantly; the Fund has saved 70 million lives since 2002. Human Rights Watch warns of preventable deaths without urgent increases.
DexEnceph Trial Shows Dexamethasone Does Not Benefit HSV Encephalitis Patients
A major UK trial found adding corticosteroid dexamethasone to aciclovir does not improve outcomes for herpes simplex virus encephalitis, the most common sporadic viral encephalitis. Despite aciclovir's survival benefits since the 1970s, many survivors face long-term cognitive issues. Results published in The Lancet Neurology guide against routine corticosteroid use.
$60M Global Consortium Launched to Combat Antibiotic Resistance
Philanthropic partners invested $60 million in a new consortium to accelerate next-generation antibiotic discovery amid the growing antimicrobial resistance crisis. This collaborative research aims to transform responses to global health challenges posed by AMR. The initiative supports broader efforts in global health innovation.
UNMC Secures Multiple Grants for Cancer, Neurological, and Infectious Disease Research
University of Nebraska Medical Center researchers received over $1M in grants, including $504K for mir-146a in aortic aneurysms and $300K each for STEMVAC vaccine trials in lung cancer and neurological studies. Additional funding supports trials for renal cell carcinoma, RSV vaccine in transplant patients, and short bowel syndrome. These highlight advances in cardiovascular, oncology, and transplant medicine.
Galderma Presents Advances in Regenerative Aesthetics at IMCAS 2026
Galderma showcased data on Sculptra's regenerative properties for face and body, including cellulite improvement, and hyaluronic acid fillers like Restylane for chin, jawline, and temples. New neuromodulator Relfydess demonstrates rapid onset by Day 1 and six-month efficacy for frown lines. Studies confirm safety, efficacy, and high patient satisfaction.
CAPLYTA Adjunctive Therapy Doubles Remission Rates in Depression Trials
Intra-Cellular Therapies' CAPLYTA nearly doubled the likelihood of remission at six weeks compared to placebo when added to antidepressants, based on pooled clinical data. This positions it as a promising option for treatment-resistant depression. Results from Janssen press releases highlight its efficacy.
World Economic Forum Discusses Path to Universal Healthcare Access
A World Economic Forum session addressed scaling AI and technology for frontline health workers to achieve healthcare for all, measuring progress by lives saved and innovations. Despite advances, resource gaps persist for the most vulnerable. Emphasis on resilient domestic solutions and global scaling.
ŌURA and NUS Launch Joint Lab for Personalized Preventive Health
ŌURA partnered with National University of Singapore to establish a joint lab advancing personalized preventive health technologies. This initiative focuses on wearable tech integration for early disease detection and wellness. It represents a step toward data-driven global health prevention.